Health Alert:

See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.

Coronavirus infected cells, under microscope | Image credit: Dr. Susan Weiss
Coronavirus infected cells | Photo credit: Dr. Susan Weiss

In response to the global health crisis, and in consultation with leadership of the Perelman School of Medicine, the Microbiology Department is proud to announce the founding of the Center for Research on Coronavirus and Other Emerging Pathogens.

The goals of the Center are to:

  1. Expand and accelerate SARS-CoV-2 research at Penn, CHOP and Wistar.
  2. Provide centralized information on SARS-CoV-2 research developments in our community and globally.
  3. Compile information and catalyze opportunities for new funding for research on SARS-CoV-2 and other emerging pathogens.

SARS-CoV-2 Resources/Research Projects at Penn

Penn Center for Research on Coronavirus and Other Emerging Pathogens

The Center will be directed by Susan Weiss, PhD, and Frederic Bushman, PhD, with a highly distinguished set of researchers from Penn Medicine, the Children's Hospital of Philadelphia (CHOP) and The Wistar Institute serving on our Internal Advisory Board. 

Support the Penn Center for Research on Coronavirus

Penn has long led the world in research on coronavirus, the virus class to which SARS-CoV-2 belongs. We are now asking for your help to support immediate needs in scaling up existing research capacity to meet increasing demand, and launch targeted new research projects.

Your support will accelerate and expand Penn’s ability to respond to this global outbreak with research in the development of new ways to diagnose, treat, and even prevent SARS-CoV-2 infections.

Donate Now

For any questions or to discuss supporting the Center, please contact the Penn Medicine Development team directly:

Clinical Trials

Penn Medicine currently has active clinical trials for patients with COVID 19, a plasma donation protocol for those that have recovered from COVID-19 and a vaccine trial for health volunteers. Each trial has different eligibility criteria. Final decision to see if someone is eligible to be in the clinical trial is made by the clinical trial team.

COVID-19 Support

In response to the COVID-19 pandemic, we are assembling teams across medicine and engineering to address emergent unmet needs.

Current teams are working on:

Please submit your needs and ideas for solutions ASAP and Penn Health-Tech will connect you to collaborators. Fill out this Health Tech form to submit.

Coronavirus Symposium

Symposium: The Coronavirus Outbreak, April 3, 2020

Share This Page: